Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Stocks Close Higher Monday Ahead of CPI Data
Kyle O’Dell, founder & CEO of EdgeRock Wealth Management, joined Cheddar News to discuss Monday’s market trading session and what to look for in Tuesday's CPI report as Wall Street continues to digest the Fed's move last month.
Load More